Oligonucleotide probes for imaging and diagnosis of bacterial infections.
Optical imaging
bacterial infections
nanocarriers
nucleic acid mimics (NAMs)
oligonucleotide probes
Journal
Critical reviews in biotechnology
ISSN: 1549-7801
Titre abrégé: Crit Rev Biotechnol
Pays: England
ID NLM: 8505177
Informations de publication
Date de publication:
03 Jun 2024
03 Jun 2024
Historique:
medline:
4
6
2024
pubmed:
4
6
2024
entrez:
3
6
2024
Statut:
aheadofprint
Résumé
The rise of infectious diseases as a public health concern has necessitated the development of rapid and precise diagnostic methods. Imaging techniques like nuclear and optical imaging provide the ability to diagnose infectious diseases within the body, eliminating delays caused by sampling and pre-enrichments of clinical samples and offering spatial information that can aid in a more informed diagnosis. Traditional molecular probes are typically created to image infected tissue without accurately identifying the pathogen. In contrast, oligonucleotides can be tailored to target specific RNA sequences, allowing for the identification of pathogens, and even generating antibiotic susceptibility profiles by focusing on drug resistance genes. Despite the benefits that nucleic acid mimics (NAMs) have provided in terms of stabilizing oligonucleotides, the inadequate delivery of these relatively large molecules into the cytoplasm of bacteria remains a challenge for widespread use of this technology. This review summarizes the key advancements in the field of oligonucleotide probes for
Identifiants
pubmed: 38830823
doi: 10.1080/07388551.2024.2344574
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM